Diagnosis and staging of prostatic carcinoma: What is really necessary?

被引：6

作者：

Schmid, HP ^{[1
]}

Oberpenning, F ^{[1
]}

Pummer, K ^{[1
]}

机构：

[1] Univ Munster, Dept Urol, D-48129 Munster, Germany

来源：

UROLOGIA INTERNATIONALIS | 1999年 / 63卷 / 01期

关键词：

diagnosis; staging; prostatic carcinoma; digital rectal examination; prostate-specific antigen; transrectal ultrasonography; pelvic lymphadenectomy; bone scintigraphy;

D O I：

10.1159/000030419

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Diagnosis and staging of prostatic carcinoma should be considered in men in whom treatment with curative intent is possible. The primary tools for detection of cancer are digital rectal examination (DRE) and serum prostate-specific antigen (PSA), whereas transrectal ultrasonography is best used to guide the needle for biopsy. Staging should be based on the TNM system. The most reliable staging methods include a combination of DRE, PSA and systematic biopsies for local tumor extension, pelvic lymphadenectomy for regional lymph nodes, and PSA and bone scintigraphy for distant metastases. Computed tomography a nd magnetic resonance imaging a re not necessary in most cases. Copyright (C) 1999 S. Karger AG, Basel.

引用

页码：57 / 61

页数：5

共 38 条

[1]

BENSON MC, 1994, CANCER-AM CANCER SOC, V74, P1667, DOI 10.1002/1097-0142(19940915)74:6<1667::AID-CNCR2820740605>3.0.CO

[2]

2-2

[3] LONGITUDINAL EVALUATION OF PROSTATE-SPECIFIC ANTIGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE DISEASE [J].